{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:24:01Z","timestamp":1790882641231,"version":"4.1.0"},"reference-count":40,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science and Higher Education of the Russian Federation","award":["075-15-2021-1085"],"award-info":[{"award-number":["075-15-2021-1085"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Objectives: Aminoglycosides are one of the first classes of natural antibiotics which have not lost relevance due to their broad spectrum of action against Gram-positive, Gram-negative bacteria and mycobacteria. The high growth rate of antimicrobial resistance (AMR) together with the severe side effects of aminoglycosides increase the importance of developing improved semisynthetic derivatives. Methods: In this work, we proposed a synthetic route to new tobramycin derivatives modified at the 6\u2033-position with aminoalkylamine or guanidinoalkylamine residues. Results: The antibacterial activity of the new compounds against reference strains of microorganisms was comparable to the parental tobramycin. In striking contrast to tobramycin (resistance index, &gt;256), its 6\u2033-modified derivatives were significantly more potent against resistant clinical isolates of P. aeruginosa strains (resistance index = 4\u201316) and they demonstrated a promising AMR circumvention in E. coli strains associated with mutations in the fusA gene encoding elongation factor G. All the obtained tobramycin derivatives exhibited reduced cytotoxicity for the eukaryotic HEK293T cells compared to the tobramycin and thereby they potentially may have improved therapeutic index. The proposed modification of the 6\u2033-position of tobramycin does not change the mechanism of aminoglycoside\u2019s antibacterial activity: new compounds induced translation errors which resulted in the inhibition of protein synthesis in bacterial cells. Conclusions: Taken together, we can suggest that further modifications of the 6\u2033-position of tobramycin may be beneficial for circumvention of AMR to aminoglycosides or used for conjugation with other molecules of interest.<\/jats:p>","DOI":"10.3390\/antibiotics13121191","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T09:55:20Z","timestamp":1733478920000},"page":"1191","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Synthesis and Antibacterial Activity of New 6\u2033-Modified Tobramycin Derivatives"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6110-3447","authenticated-orcid":false,"given":"Kseniya S.","family":"Shapovalova","sequence":"first","affiliation":[{"name":"Gause Institute of New Antibiotics, 11 B. Pirogovskaya Street, Moscow 119021, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgy V.","family":"Zatonsky","sequence":"additional","affiliation":[{"name":"Gause Institute of New Antibiotics, 11 B. Pirogovskaya Street, Moscow 119021, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizaveta A.","family":"Razumova","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria A.","family":"Ipatova","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1413-9559","authenticated-orcid":false,"given":"Dmitrii A.","family":"Lukianov","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1, Moscow 119991, Russia"},{"name":"Center for Molecular and Cellular Biology, Moscow 121205, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr V.","family":"Sergiev","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1, Moscow 119991, Russia"},{"name":"Center for Molecular and Cellular Biology, Moscow 121205, Russia"},{"name":"A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119991, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3508-231X","authenticated-orcid":false,"given":"Natalia E.","family":"Grammatikova","sequence":"additional","affiliation":[{"name":"Gause Institute of New Antibiotics, 11 B. Pirogovskaya Street, Moscow 119021, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6418-1539","authenticated-orcid":false,"given":"Alexander S.","family":"Tikhomirov","sequence":"additional","affiliation":[{"name":"Gause Institute of New Antibiotics, 11 B. Pirogovskaya Street, Moscow 119021, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6595-0811","authenticated-orcid":false,"given":"Andrey E.","family":"Shchekotikhin","sequence":"additional","affiliation":[{"name":"Gause Institute of New Antibiotics, 11 B. Pirogovskaya Street, Moscow 119021, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1080\/10408398.2015.1077192","article-title":"Antimicrobial Resistance: A Global Emerging Threat to Public Health Systems","volume":"57","author":"Ferri","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"100940","DOI":"10.1016\/j.lanmic.2024.07.003","article-title":"WHO publishes updated list of bacterial priority pathogens","volume":"5","author":"Jesudason","year":"2024","journal-title":"Lancet Microbe"},{"key":"ref_3","unstructured":"O\u2019Neill, J. (2016). Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. Review on Antimicrobial Resistance, Wellcome Trust."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Menzies, D., Benedetti, A., Paydar, A., Martin, I., Royce, S., Pai, M., Vernon, A., Lienhardt, C., and Burman, W. (2009). Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-analysis. PLoS Med., 6.","DOI":"10.1371\/journal.pmed.1000146"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.58838\/2075-1230-2024-102-1-82-86","article-title":"Treatment with Inhaled Antibiotics as One of the Measures to Combat Bacterial Resistance (Cystic Fibrosis is Used as an Example)","volume":"102","author":"Takhtamysheva","year":"2024","journal-title":"Tuberc. Lung Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"212527","DOI":"10.7573\/dic.212527","article-title":"How to manage Pseudomonas aeruginosa infections","volume":"7","author":"Bassetti","year":"2018","journal-title":"Drugs Context"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e00181-19","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial resistance in ESKAPE pathogens","volume":"33","author":"Forde","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Thacharodi, A., and Lamont, I.L. (2023). Gene\u2013gene interactions reduce aminoglycoside susceptibility of Pseudomonas aeruginosa through efflux pump-dependent and-independent mechanisms. Antibiotics, 12.","DOI":"10.3390\/antibiotics12010152"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/138161207779313731","article-title":"Aminoglycoside-Induced Ototoxicity","volume":"13","author":"Selimoglu","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ki.2010.337","article-title":"New Insights into the Mechanism of Aminoglycoside Nephrotoxicity: An Integrative Point of View","volume":"79","author":"Quiros","year":"2011","journal-title":"Kidney Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"a027029","DOI":"10.1101\/cshperspect.a027029","article-title":"Aminoglycosides: An Overview","volume":"6","author":"Krause","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_12","first-page":"553","article-title":"Antibiotics in the Pipeline: A Literature Review (2017\u20132020)","volume":"50","author":"Momattin","year":"2021","journal-title":"Infection"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s11094-021-02510-0","article-title":"Potential for the Development of a New Generation of Aminoglycoside Antibiotics","volume":"55","author":"Tevyashova","year":"2021","journal-title":"Pharm. Chem. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1039\/C7CS00407A","article-title":"Comprehensive Review of Chemical Strategies for the Preparation of New Aminoglycosides and Their Biological Activities","volume":"47","author":"Chandrika","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ja.2012.59","article-title":"Antibacterial activity of amphiphilic tobramycin","volume":"65","author":"Dhondikubeer","year":"2012","journal-title":"J. Antibiot."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1002\/chem.201406404","article-title":"Tobramycin and nebramine as pseudo-oligosaccharide scaffolds for the development of antimicrobial cationic amphiphiles","volume":"21","author":"Herzog","year":"2015","journal-title":"Chemistry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1002\/anie.201200761","article-title":"6\u2033-thioether tobramycin analogues: Towards selective targeting of bacterial membranes","volume":"51","author":"Herzog","year":"2012","journal-title":"Angew. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1002\/anie.201500598","article-title":"Amphiphilic tobramycins with immunomodulatory properties","volume":"54","author":"Guchhait","year":"2015","journal-title":"Angew. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/cbic.201500256","article-title":"Tobramycin variants with enhanced ribosome-targeting activity","volume":"16","author":"Fosso","year":"2015","journal-title":"ChemBioChem"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1039\/C2MD20162C","article-title":"Design of membrane targeting tobramycin-based cationic amphiphiles with reduced hemolytic activity","volume":"4","author":"Herzog","year":"2013","journal-title":"MedChemComm"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1021\/acs.jmedchem.5b01375","article-title":"Synthesis and bioactivities of kanamycin B-derived cationic amphiphiles","volume":"58","author":"Fosso","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1128\/AAC.00229-15","article-title":"Amphiphilic tobramycin analogues as antibacterial and antifungal agents","volume":"59","author":"Shrestha","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Fosso, M.Y., Shrestha, S.K., Thamban Chandrika, N., Dennis, E.K., Green, K.D., and Garneau-Tsodikova, S. (2018). Differential effects of linkers on the activity of amphiphilic tobramycin antifungals. Molecules, 23.","DOI":"10.3390\/molecules23040899"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Tevyashova, A., Efimova, S., Alexandrov, A., Omelchuk, O., Ghazy, E., Bychkova, E., Zatonsky, G., Grammatikova, N., Dezhenkova, L., and Solovieva, S. (2023). Semisynthetic amides of amphotericin B and nystatin A1: A comparative study of in vitro activity\/toxicity ratio in relation to selectivity to ergosterol membranes. Antibiotics, 12.","DOI":"10.3390\/antibiotics12010151"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Moiseenko, E.I., Erdei, R., Grammatikova, N.E., Mirchink, E.P., Isakova, E.B., Pereverzeva, E.R., Batta, G., and Shchekotikhin, A.E. (2021). Aminoalkylamides of eremomycin exhibit an improved antibacterial activity. Pharmaceuticals, 14.","DOI":"10.3390\/ph14040379"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1134\/S0006297919010085","article-title":"The Effect of Antitumor Antibiotic Olivomycin A and Its New Semi-synthetic Derivative Olivamide on the Activity of Murine DNA Methyltransferase Dnmt3a","volume":"84","author":"Sergeev","year":"2019","journal-title":"Biochem. Mosc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1021\/acsinfecdis.3c00217","article-title":"Guanidinylated Amphiphilic Tobramycin Derivatives Synergize with \u03b2-Lactam\/\u03b2-Lactamase Inhibitor Combinations against Pseudomonas aeruginosa","volume":"9","author":"Ramirez","year":"2023","journal-title":"ACS Infect Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1021\/acs.jnatprod.1c00162","article-title":"Water-soluble heliomycin derivatives to target i-Motif DNA","volume":"84","author":"Tikhomirov","year":"2021","journal-title":"J. Nat. Prod."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Shapovalova, K., Zatonsky, G., Grammatikova, N., Osterman, I., Razumova, E., Shchekotikhin, A., and Tevyashova, A. (2023). Synthesis of 6\u2033-Modified Kanamycin A Derivatives and Evaluation of Their Antibacterial Properties. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15041177"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ja.2017.131","article-title":"Cellular uptake of modified aminoglycosides","volume":"71","author":"Hadidi","year":"2018","journal-title":"J. Antibiot."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/dnares\/dsu032","article-title":"Genomic analysis reveals distinct concentration-dependent evolutionary trajectories for antibiotic resistance in Escherichia coli","volume":"21","author":"Mogre","year":"2014","journal-title":"DNA Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1534\/g3.117.300284","article-title":"Modulation of global transcriptional regulatory networks as a strategy for increasing kanamycin resistance of the translational elongation factor-G mutants in Escherichia coli","volume":"7","author":"Mogre","year":"2017","journal-title":"G3 Genes Genomes Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., and Mori, H. (2006). Construction of Escherichia coli K-12 in frame, single gene knockout mutants: The Keio collection. Mol. Syst. Biol., 2.","DOI":"10.1038\/msb4100050"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Jospe-Kaufman, M., Siomin, L., and Fridman, M. (2020). The relationship between the structure and toxicity of aminoglycoside antibiotics. Bioorg. Med. Chem. Lett., 30.","DOI":"10.1016\/j.bmcl.2020.127218"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1261\/rna.039792.113","article-title":"Studies of translational misreading in vivo show that the ribosome very efficiently discriminates against most potential errors","volume":"20","author":"Manickam","year":"2014","journal-title":"RNA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0968-0896(99)00071-1","article-title":"Enhanced RNA binding of dimerized aminoglycosides","volume":"7","author":"Michael","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"ref_38","unstructured":"(2015). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Approved Standard, 10th ed (Standard No. M07-A10)."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1073\/pnas.120163297","article-title":"One-Step Inactivation of Chromosomal Genes in Escherichia Coli K-12 Using PCR Products","volume":"97","author":"Datsenko","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.32607\/actanaturae.11654","article-title":"Imidazole Derivative As a Novel Translation Inhibitor","volume":"14","author":"Lukianov","year":"2022","journal-title":"Acta Nat."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/13\/12\/1191\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:48:57Z","timestamp":1760114937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/13\/12\/1191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["antibiotics13121191"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics13121191","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]}}}